During question time in the National Assembly on 11 February, opposition MPs pressed Interior Minister Laurent Nuñez over what they called an “exploding” number of residence permits issued for medical treatment (titres de séjour pour soins). Citing a recent Council of State ruling that annulled one rejected case on procedural grounds, deputies from the Rassemblement National argued that up to 30,000 foreign patients apply each year, burdening the social-security budget.
Nuñez rejected the figures, stating that while applications hover around 30,000, approvals are much lower and subject to stringent medical-committee review. He emphasised that applicants must already be on French soil and cannot obtain such visas from abroad, undercutting claims of a pull factor. The exchange underscores the political sensitivity of humanitarian immigration channels just weeks before Senate deliberations on a broader immigration reform package.
![Assembly Grills Interior Minister on Cost of Medical Stay Permits]()
For employers and universities that occasionally sponsor staff or students requiring specialised treatment, the debate signals no immediate policy change but hints at tighter scrutiny by prefectures. Mobility teams should ensure that any medical-stay applications are meticulously documented and routed through the Office Français de l’Immigration et de l’Intégration (OFII) to avoid delays.
The spat also highlights a wider trend: parliamentary questions are increasingly used to challenge executive discretion on niche immigration categories—from posted-worker notifications to talent-passport renewals—creating a more unpredictable compliance environment. Companies should monitor forthcoming committee hearings, where amendments to the draft immigration bill could introduce new reporting duties for employers of foreign nationals.
While the cost argument makes headlines, public-health economists note that medical permits represent less than 0.2 % of France’s annual healthcare budget. However, the political heat around the issue means that any isolated fraud cases could trigger rapid regulatory tightening.
Nuñez rejected the figures, stating that while applications hover around 30,000, approvals are much lower and subject to stringent medical-committee review. He emphasised that applicants must already be on French soil and cannot obtain such visas from abroad, undercutting claims of a pull factor. The exchange underscores the political sensitivity of humanitarian immigration channels just weeks before Senate deliberations on a broader immigration reform package.
For employers and universities that occasionally sponsor staff or students requiring specialised treatment, the debate signals no immediate policy change but hints at tighter scrutiny by prefectures. Mobility teams should ensure that any medical-stay applications are meticulously documented and routed through the Office Français de l’Immigration et de l’Intégration (OFII) to avoid delays.
The spat also highlights a wider trend: parliamentary questions are increasingly used to challenge executive discretion on niche immigration categories—from posted-worker notifications to talent-passport renewals—creating a more unpredictable compliance environment. Companies should monitor forthcoming committee hearings, where amendments to the draft immigration bill could introduce new reporting duties for employers of foreign nationals.
While the cost argument makes headlines, public-health economists note that medical permits represent less than 0.2 % of France’s annual healthcare budget. However, the political heat around the issue means that any isolated fraud cases could trigger rapid regulatory tightening.
